Anthony Doyle, Chief Financial Officer at BIOCRYST PHARMACEUTICALS INC (BCRX), bought 70,516 shares at $12.48 ($880K) on 2021-11-23, disclosed to the SEC on 2021-11-24.
High-signal trade — passes our conviction filters but the AI narrative is still being generated. Check back shortly.
Clearly above the average filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $12.48 | 35,258 | $440K | 50.0% |
| 2 | $12.48 | 35,258 | $440K | 50.0% |
| Total | $12.48 avg | 70,516 | $880K | 100% |
| Filing → |
| BCRX | BUY | 2020-08-12 | $220K | — | Filing → |